Dubai welcomes three Longevium clinics as longevity medicine enters a new era
AI-driven diagnostics aim to track and slow biological ageing
DUBAI – Dubai's push to become a global hub for advanced healthcare and longevity medicine has gained further momentum with the launch of three new Longevium clinics across the emirate.
The next-generation clinic network has opened facilities in Jumeirah 3, Jumeirah Lake Towers and Jumeirah Village Circle, bringing together nearly 100 physicians and specialists under a new clinical model focused on healthy ageing. The expansion comes as Dubai continues to strengthen its healthcare ecosystem through new initiatives and rising demand for medical services.
The launch follows the establishment of the Dubai Longevity Authority, which oversees the emirate's longevity, wellness and advanced health sectors. It also comes after the Dubai Health Authority (DHA) reported strong growth in healthcare insurance activity during 2025, with more than 4.9 million insured beneficiaries, an increase of around 6.5 percent from 2024. Insurance claims climbed approximately 13.5 percent to 49.6 million, supported by a healthcare ecosystem comprising 3,936 providers, 140 insurance brokers, 43 insurance companies and 16 claims management entities.
Integrated care
Longevium said its clinical approach is designed to help patients predict, monitor and slow biological ageing by combining advanced diagnostics, artificial intelligence, regenerative medicine and personalised healthspan extension programmes.
Its flagship clinic is located at Triple Seven Mall in Jumeirah 3, alongside branches in Jumeirah Lake Towers and Jumeirah Village Circle. The three locations are intended to improve access to longevity medicine across central, residential and high-demand districts of Dubai.
"Longevium is building a measurable medical system for longevity," said Dr Ksenia Butova, Founder and Chief Executive Officer of Longevium.
She said healthy ageing should be managed through diagnostics, biomarkers, physician supervision, long-term monitoring and personalised clinical protocols. The aim, she added, is to help patients understand their health trajectory before disease develops and intervene early to change that course.
Rather than offering isolated treatments, the clinic's model is built around continuous patient care. Each patient undergoes biological age assessment alongside laboratory testing, body composition analysis, cardiovascular risk evaluation, metabolic marker assessments and lifestyle reviews, creating a single clinical profile.
The company's proprietary AI platform supports physicians by tracking patient progress over time, measuring the effectiveness of interventions and refining treatment protocols using each patient's biomarkers.
Clinical approach
According to Dr Butova, Dubai has become one of the world's most attractive environments for the future of medicine as longevity research, biotechnology, artificial intelligence, preventive healthcare and regenerative medicine continue to develop together.
She said these developments were among the reasons Longevium chose Dubai as its launch market, adding that the UAE has the potential to become an international reference point for longevity medicine.
The clinic's services include advanced diagnostic programmes, biological age tracking, peptide-based protocols, exosome therapies, stem cell approaches, GLP-1 metabolic optimisation, hormone balance programmes, cardiovascular prevention and regenerative aesthetic treatments. The programmes are designed primarily for entrepreneurs, executives, high-performing professionals and international patients seeking measurable biological outcomes rather than conventional wellness services.
Patient journey
A key feature of the model is the introduction of Longevity Day, a physician-led three-hour assessment programme intended to provide patients with a comprehensive understanding of their biological age, health risks and personalised optimisation strategy during a single visit.
The programme combines consultations with multiple specialists, advanced biomarker testing, ultrasound and vascular imaging, peptide and supplement planning, IV therapy and aesthetic regeneration into one structured clinical roadmap.
Dr Butova said longevity medicine must become increasingly evidence-based, transparent and measurable. Instead of relying on one-off treatments, she said the focus should be on continuously monitoring biological signals and adjusting protocols with medical precision to support long-term healthspan.
She added that more people are choosing to understand their biological age, identify health risks, improve performance and extend the number of years they remain healthy, active and productive, reflecting a growing shift towards preventive healthcare in Dubai's evolving medical landscape.